Henneman John B III

Henneman John B III is listed in filings as Director at Orthofix Medical Inc.. This profile follows SEC Form 4 activity through May 8, 2026, including purchase activity. Recent filings connect the profile to Orthofix Medical Inc. (OFIX), Anika Therapeutics, Inc. (ANIK), Aprea Therapeutics, Inc. (APRE), and R1 RCM Inc. (RCM). The current snapshot covers public activity from Jun 20, 2024 to May 8, 2026. Reported amounts are shown as $61.3K to $7.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.